Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor dif
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma | Scientific Reports
Anti-h PIVKA-II 12102 SPTN-5
Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
Elecsys® PIVKA-II
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma - Tian - 2023 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Comparison of AFP and PIVKA-II level in different grades and stages of... | Download Table
Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... | Download Scientific Diagram
Premium Photo | Pivka ii or protein induced by vitamin k ii test a screening marker for hepatocellular carcinoma
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
The Relationship between Serum PIVKA-II Levels and the Severity of... | Download Table
Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II - ScienceDirect
Evaluation of Diagnostic Utility of Protein Induced by Vitamin K Absence–II (PIVKA-II) in Hepatocellular Carcinoma
Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients | Scientific Reports
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma | PLOS ONE
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Frontiers | Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data | BMC Cancer | Full Text
